Skip to main content
Clinical Trials/NL-OMON52506
NL-OMON52506
Completed
N/A

The contribution of genetic predisposition to pediatric cancer: a study integrating extensive phenotyping and state of the art genotyping. - PrediCT - Predispostion to Childhood Tumors

Prinses Máxima Centrum voor Kinderoncologie0 sites843 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Prinses Máxima Centrum voor Kinderoncologie
Enrollment
843
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Prinses Máxima Centrum voor Kinderoncologie

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria for the main study PrediCT:
  • \- Children (age \< 19 years) newly diagnosed with cancer or neoplasms at the
  • Princess Máxima Center (in a period
  • of three years)
  • \- Written informed consent (by patient when aged 16 years or older, by patient
  • and parent(s) when aged 12\-16
  • years, by parent(s) when younger than 12 years)
  • Additional inclusion criteria for REFLECT:
  • \- Consent for participation in PrediCT
  • \- Written informed consent for REFLECT. This can include:

Exclusion Criteria

  • Children and/or their parents who don't want to know the results of the DNA
  • test (pediatric cancer gene panel
  • Additional exclusion criterion for REFLECT: Insufficient proficiency in Dutch.

Outcomes

Primary Outcomes

Not specified

Similar Trials